Techniques for delivery of stem cell and related therapies to treat cardiac conditions

• US 8,175,704 B2
• Filed: 07/22/2010
• Issued: 05/08/2012
• Est. Priority Date: 11/03/2006
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Koh, Steve
• Primary Examiner(s): Patel, Niketa
• Assistant Examiner(s): EL-KAISSI, HIBA CARINE
• Application Number:
  US12/841,913
• Publication Number:
  US 20100286652A1
• Time in Patent Office: 656 Days
• Field of Search: 607/3, 607/6, 607/120, 600/510, 604/890.1
• US Class Current: 607/9
• CPC Class Codes: A61M 2210/125 Heart
• CPC Class Codes: A61M 2230/04 Heartbeat characteristics, e.g. ECG, blood pressure modulation
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/371 Capture, i.e. successful stimulation

Abstract

An exemplary method includes acquiring cardiac electrical activity information; detecting cardiac events within the information including T waves, QRS complexes and/or P waves; and calling for delivery of matter to the heart during a period of time based on the cardiac events. The delivery may occur between a detected T wave and its immediately subsequent QRS complex. The matter being delivered may include stem cells, progenitor cells, nutrients and/or drugs.

Claims

1. A method comprising:

acquiring cardiac electrical activity information using at least two electrodes positioned on a surface of a distal end of a lead implanted adjacent cardiac tissue, wherein the lead includes at least one opening through the surface on which the at least two electrodes are positioned, wherein the opening is positioned between the at least two electrodes;

detecting cardiac events within the information including T waves, QRS complexes and P waves;

measuring impedance between two of the electrodes; and

when the impedance measurement indicates the at least one opening is in cardiac tissue, delivering matter to the heart through the at least one opening through the surface on which the at least two electrodes are positioned, wherein the opening is positioned between the at least two electrodes, wherein delivery occurs at a time between a detected T wave and its immediately subsequent QRS complex, and

when the impedance measurement indicates the at least one opening is not in cardiac tissue, prohibiting the delivery of matter to the heart through the at least one opening;

wherein the measuring and delivering occur repeatedly and incrementally after the detection of the cardiac events.

2. The method of claim 1 wherein the acquiring comprises acquiring an EGM.

3. The method of claim 2 wherein the acquiring comprises acquiring the EGM using an implantable device.

4. The method of claim 1 wherein the matter comprises at least one member selected from a group consisting of stem cells, progenitor cells, nutrients and drugs.

5. The method of claim 1 further comprising using the measured impedance to determine if matter delivered is in contact with the electrodes.

6. The method of claim 1 further comprising using the measured impedance to determine if fouling has occurred at the at least one opening.

7. The method of claim 1 further comprising generating an electro-magnetic field using the at least two electrodes.

8. The method of claim 1 wherein the at least one opening is defined by a prong extending outward from the surface on which the at least two electrodes are positioned, wherein the prong is positioned between the at least two electrodes.

9. The method of claim 1 wherein the lead includes a plurality of openings, each defined by a prong extending outward from the surface on which the at least two electrodes are positioned, wherein the prong is positioned between the at least two electrodes and at least two of the prongs have different lengths.

10. The method of claim 1 wherein the distal end of the lead comprises a screw structure defining the surface on which the at least two electrodes are positioned and through which the opening extends.

11. The method of claim 1 wherein the matter comprises cells and further comprising delivering one or more cell conditioning pulses to the cells delivered to the heart.

12. The method of claim 11 wherein the one or more cell conditioning pulses comprise an energy insufficient to capture the heart.

13. A method comprising:

acquiring cardiac electrical activity information using at least two electrodes positioned on a surface of a distal end of a lead implanted adjacent cardiac tissue, wherein the lead includes at least one opening through the surface on which the at least two electrodes are positioned, wherein the opening is positioned between the at least two electrodes;

detecting cardiac events within the information including T waves, QRS complexes and P waves;

measuring impedance between two of the electrodes; and

when the impedance measurement indicates the at least one opening is in cardiac tissue, delivering matter to the heart through the at least one opening through the surface on which the at least two electrodes are positioned, wherein the opening is positioned between the at least two electrodes, wherein delivery occurs at a time between a detected T wave and its immediately subsequent P wave; and

when the impedance measurement indicates the at least one opening is not in cardiac tissue, prohibiting the delivery of matter to the heart through the at least one opening;

wherein the measuring and delivering occur repeatedly and incrementally after the detection of the cardiac events.

14. The method of claim 13 wherein the matter comprises at least one member selected from a group consisting of stem cells, progenitor cells, nutrients and drugs.